B

Bristol Myers Squibb

Makes drugs for cancer, blood and immune diseases

Market Access and HEOR Manager

Business & StrategyConfirmed live in the last 24 hours
Full-timeDubai - United Arab EmiratesNo salary listed

About the Job

Requirements

  • A Bachelor's degree in Pharmacy, Medicine, Health Economics, Public Health, Life Sciences, or a related field is required.
  • At least 5 years of experience in Market Access, HEOR, Health Policy, Reimbursement, or related functions within the pharmaceutical industry is required.
  • Demonstrated experience leading HTA submissions, reimbursement dossiers, or health economic evaluations is required.
  • Experience developing payer value propositions and adapting global HEOR evidence for local markets is required.
  • Strong understanding of Gulf healthcare systems, reimbursement pathways, and emerging HTA frameworks is required.
  • Experience designing, implementing, or supporting Patient Support Programs and patient access initiatives is required.
  • A proven track record of successful reimbursement, formulary inclusion, and payer engagement outcomes is required.
  • Strong analytical, project management, and stakeholder engagement capabilities are required.
  • Fluent English is required.
  • Travel is required.
  • A strong understanding of payer decision-making and value-based healthcare is required.
  • The ability to translate scientific and economic evidence into reimbursement success is required.
  • Strategic thinking and execution capability are required.
  • External stakeholder engagement and influencing skills are required.

Responsibilities

  • Lead the development and implementation of local HEOR strategies across Gulf countries and Jordan.
  • Partner with regional and global HEOR teams to adapt global evidence packages and generate locally relevant economic and outcomes evidence.
  • Identify evidence gaps and develop plans for burden-of-illness studies, real-world evidence generation, patient-reported outcomes, cost-effectiveness analyses, budget impact models, and healthcare resource utilization studies.
  • Develop country-specific value dossiers and payer evidence packages demonstrating the clinical, economic, and societal value of BMS therapies.
  • Build relationships with academic institutions, HTA experts, health economists, and key opinion leaders to strengthen local evidence-generation capabilities.
  • Monitor emerging HEOR methodologies, payer evidence requirements, and evolving HTA frameworks across the region.
  • Lead the development, submission, and defense of HTA dossiers across Gulf countries and Jordan.
  • Serve as the primary access lead for reimbursement submissions, health economic evaluations, budget impact analyses, and value assessments required by payers and regulatory authorities.
  • Work cross-functionally to ensure robust evidence packages are available for pricing, reimbursement, and formulary decision-making.
  • Develop and execute strategies to address payer evidence requirements and strengthen reimbursement outcomes.
  • Support pricing negotiations through health economic evidence and value-based arguments.
  • Monitor evolving HTA regulations and reimbursement policies and proactively shape access strategies accordingly.
  • Lead the development of Patient Support Program strategies aligned with market access objectives and patient needs.
  • Work with external partners, Medical, Compliance, and Commercial teams to design, implement, and optimize Patient Support Programs that improve patient access, adherence, persistence, and health outcomes.
  • Assess Patient Support Program impact through defined outcome metrics and generate evidence demonstrating program value to healthcare systems.
  • Explore innovative access models and value-based healthcare solutions addressing affordability, access barriers, and patient experience.
  • Work with patient advocacy groups, healthcare providers, and external stakeholders to identify unmet patient needs and strengthen patient-centric access solutions.
  • Develop and maintain strategic relationships with government health authorities, reimbursement bodies, HTA agencies, payers, procurement organizations, and healthcare institutions.
  • Position BMS as a trusted partner in healthcare system transformation, value-based healthcare, and access innovation discussions.
  • Lead development of economic value communications for relevant teams to use with payers, decision-makers, and formulary committees.
  • Support policy-shaping initiatives that promote evidence-based access and adoption of innovative therapies.
  • Monitor healthcare reforms, pharmaceutical funding mechanisms, and payer priorities to identify emerging opportunities and risks.
  • Partner with Key Account Managers, providing direction and expert input on translating payer insights and value messages into successful account-level access strategies.
  • Support the head of Markets Access in developing and executing access plans for new product launches and new indications.
  • Support formulary submissions and value communication efforts across healthcare institutions and national decision-making bodies.
  • Track and report access milestones, reimbursement outcomes, and access-related KPIs.
  • Act as the access subject matter expert for HEOR, HTA, reimbursement, Patient Support Programs, and payer evidence requirements.
  • Ensure alignment among Market Access, Medical Affairs, Regulatory, Commercial, Government Affairs, Finance, and regional and global teams.
  • Contribute to launch excellence, lifecycle management, and long-term access planning across the BMS portfolio.
  • Provide strategic recommendations to senior leadership regarding market access risks, opportunities, and emerging healthcare policy developments.
  • Ensure full compliance with local regulations, industry codes, and BMS Standards of Business Conduct and Ethics.

Desired Qualifications

  • An advanced degree is preferred, such as an MBA, MPH, MSc in Health Economics, or equivalent.
  • Arabic fluency is highly desirable.

About the Company

Bristol Myers Squibb

Makes drugs for cancer, blood and immune diseases

Bristol Myers Squibb discovers, develops and sells prescription medicines for serious illnesses, including cancer, blood disorders, immune diseases and heart disease, for patients treated by doctors and hospitals around the world. Its best-known drug is Opdivo, an immunotherapy that helps the body's own immune system find and attack many kinds of cancer. Researchers develop drug candidates in its labs or bring them in through acquisitions and partnerships, then test them in clinical trials to win regulatory approval. The company makes and markets the approved medicines and earns its revenue from sales of patent-protected drugs. Its roots go back to a business founded in 1887, and it is based in Lawrence Township, New Jersey.

Company size
10,001+
Company stage
IPO
Headquarters
Lawrence Township, NJ
Founded
1887

Recently Posted Jobs

Explore more opportunities at Bristol Myers Squibb

See more jobs